Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...

These stocks have strong revenue and earnings growth potential for 2025. These are: PLTR, CRWD, CEG, CVNA, IBKR.

Today you can access their live picks without cost or obligation ... expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking ...

this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% ...

The stock is currently a Zacks Rank #4 (Sell), reflective of bearishness ... Today you can access their live picks without cost or obligation. Just released: Experts distill 7 elite stocks from ...

Let's take a closer look at revisions and a few other key metrics to keep an eye on. Analysts have been quiet concerning their EPS revisions, with the $2.36 Zacks Consensus EPS estimate unchanged over ...

Welcome to Episode #430 of the Zacks Market Edge Podcast. Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds, ...

Zacks Investment Research Image Source: Zacks Investment Research DexCom’s rapid expansion was driven by its innovations and its soaring addressable market. Over 1 in 10 American adults have diabetes ...